VEGZELMA

Google image searchProduct monograph

Active ingredient

bevacizumab, 400 MG/16 ML

DIN: 02534185

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Schedule: Prescription / Schedule D

Company: CELLTRION INC.

Date: 28-MAR-2024

ATC:

Reference brand drug: Avastin

Search on Google